Dako is integrating with Agilent on November 1, 2016. Find out what this means to you as a customer.
Leading the way
in PD-L1 testing
Introducing the first and only FDA-approved test to assess patients with NSCLC for KEYTRUDA® (pembrolizumab).
Results you can trust
The first and only FDA-approved and
CE-IVD marked PD-L1 test for use in both
non-squamous NSCLC and melanoma.
Making an impact means changing lives
Demand precision - Push the boundaries of what's possible today with exceptional quality pathology solutions.
Dako is integrating with Agilent
Read here what this means to you as a customer from November 1st.
2016 Product Catalog
The 2016 Pathology Product Catalog is now available for download.
Events and Congresses
Meet us at congresses and events around the world.